Updated progression-free survival from presto: a phase 3 randomized study of androgen annihilation for high-risk biochemically relapsed prostate cancer (aft-19)
JOURNAL OF UROLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF UROLOGY(2023)